The number of people taking a vital anti-HIV drug has fallen by almost two-fifths in just one year in the aftermath of ...

Cuts from the U.S. and others have hit hard, with the number of people receiving PrEP dropping by 38% from 2024 to 2025, ...

PrEP prevents HIV by 99%. The problem was never the drug. Wisp and Mount Sinai just launched a new model to fix how it gets ...

In a far-reaching effort to understand the factors contributing to HIV transmission among sexual and gender minority (SGM) individuals and improve HIV prevention strategies, a team of scientists at ...

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Shionogi as a shareholder, today announced the ...

Five movers and shakers in the sexual health space discuss why they think HIV prevention options should be in your intimacy ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A brand new drug might be more effective at preventing HIV than current ...

A total of 15,000 doses of injectable Lenacapavir (LEN) for use as a pre-exposure prophylaxis (PrEP) against HIV are expected ...

Pre-exposure prophylaxis (PrEP) has emerged as a transformative biomedical intervention capable of reducing HIV transmission risk by up to 99% when adherence is optimal. Initially piloted in ...

Pre-exposure prophylaxis (PrEP) has revolutionised HIV prevention by offering antiretroviral medication to HIV-negative individuals at substantial risk of infection. Widespread adoption has delivered ...

HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. A new pre-exposure prophylaxis (PrEP) drug has shown promise as a ...